7XWX image
Deposition Date 2022-05-27
Release Date 2023-02-08
Last Version Date 2023-11-29
Entry Detail
PDB ID:
7XWX
Keywords:
Title:
Crystal structure of SARS-CoV-2 N-CTD
Biological Source:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.00 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.22
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Nucleoprotein
Gene (Uniprot):N
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:100
Number of Molecules:8
Biological Source:Severe acute respiratory syndrome coronavirus 2
Ligand Molecules
Primary Citation
Antiviral drug design based on structural insights into the N-terminal domain and C-terminal domain of the SARS-CoV-2 nucleocapsid protein.
Sci Bull (Beijing) 67 2327 2335 (2022)
PMID: 36317101 DOI: 10.1016/j.scib.2022.10.021

Abstact

Nucleocapsid (N) protein plays crucial roles in the life cycle of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including the formation of ribonucleoprotein (RNP) complex with the viral RNA. Here we reported the crystal structures of the N-terminal domain (NTD) and C-terminal domain (CTD) of the N protein and an NTD-RNA complex. Our structures reveal a unique tetramer organization of NTD and identify a distinct RNA binding mode in the NTD-RNA complex, which could contribute to the formation of the RNP complex. We also screened small molecule inhibitors of N-NTD and N-CTD and discovered that ceftriaxone sodium, an antibiotic, can block the binding of RNA to NTD and inhibit the formation of the RNP complex. These results together could facilitate the further research of antiviral drug design targeting N protein.

Legend

Protein

Chemical

Disease

Primary Citation of related structures